Avience Biomedicals Ltd. IPO

Avience Biomedicals

• Avience Biomedicals is coming out with an initial public offering (IPO) of 14,53,800 shares in a price band of Rs 196-208 per equity share. 
• The issue will open on June 18, 2026 and will close on June 22, 2026.
• The shares will be listed on SME Platform of NSE.
• The face value of the share is Rs 10 and is priced 19.60 times of its face value on the lower side and 20.80 times on the higher side.
• Book running lead manager to the issue is Fintellectual Corporate Advisors.
• Compliance officer for the issue is Manoj Kumar.

Profile of the company

Avience Biomedicals is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India. It commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions. The company has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs. Being majorly into B2B and B2C market, its products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing, the company also act as distributors and traders of medical equipment.

The company operates from its manufacturing facility located in Uttar Pradesh. This facility is equipped with advanced processing capabilities and staffed with industry experts. This proactive approach empowers medical professionals with essential tools to combat diseases effectively, particularly emerging viruses. 

As an ISO 9001:2016, ISO 13485, ZED MSME Gold and Good Manufacturing Practice (GMP) certified organization, it adheres to a robust Quality Management System. Its dedication lies in providing work of such quality that aligns with project standards and specifications for materials, workmanship, schedules, and public service. It is committed to profitability and competitiveness while ensuring continual improvement through quality processes overseen by its management team. Its quality control process guarantees high standards of safety and environmental protection, meeting client expectations and adhering to their defined standards and specifications. Its commitment to perfection and quality has been evident through its rigorous adherence to regulatory norms established by the Central Drugs Standard Control Organization (CDSCO), ensuring that its production line operates at its performance.

Proceed is being used for:

• Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh 
• Funding the working capital requirement 
• Meeting out the general corporate purposes

Industry overview

India’s healthcare and medical device sectors have grown rapidly over the past decade, positioning the country as the fourth-largest medical devices market in Asia and among the top 20 globally. The industry produces a wide range of products, from consumables such as syringes and catheters to high-value implants like cardiac stents, intraocular lenses, and orthopaedic devices. While India still imports 70-80% of its medical devices, this gap offers a significant growth opportunity. Both domestic and global manufacturers are investing to meet rising demand, supported by government policies that have recognized medical devices as a sunrise sector since the launch of Make in India in 2014. The medical devices sector in India is an essential and integral constituent of the Indian healthcare sector, particularly for the prevention, diagnosis, treatment and management of all medical conditions, diseases, illnesses, and disabilities.

India is among the top 20 markets for medical devices worldwide. The medical devices sector in India comprises large multinationals and small and midsized companies. The current market size of the medical devices industry in India is estimated at $15.35 billion in 2023 and is expected to grow to $20.51 billion by 2029 with a CAGR of 5.35%. India is the fastest growing medical devices market amongst the emerging markets. The medical devices industry in India consists of large multinationals as well as small and medium enterprises (SMEs) growing at an unprecedented scale.

The Government of India has taken several steps to ensure the growth of a vibrant ecosystem of medical devices manufacturing in India. To enhance India’s manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector, a scheme called ‘Production Linked Incentive Scheme for Pharmaceuticals’ has been approved by the Government of India on March 24, 2021. The guidelines of the scheme were issued on June 1, 2021. The scheme covers Invitro diagnostic devices amongst other pharmaceutical goods. 

Pros and strengths

Innovative product portfolio: The company is proud to offer an extensive portfolio of IVD Rapid Tests and advanced medical devices designed to address healthcare challenges today. From high-performance diagnostic tests for infectious diseases to haematology and biochemistry analyzers, it is committed to bringing innovative products to market that improve patient outcomes. Additionally, as a trusted channel partner for Mindray, it extends its portfolio to include their world-class biochemistry analyzers and haematology equipment, further enriching its range of solutions.

Strong regulatory compliance: Its products adhere to some of the most rigorous international quality and safety standards, including ISO 13485 for medical device quality management, ISO 9001 for overall organizational quality management, CE marking for compliance with European Union health, safety, and environmental protection regulations, and GMP (Good Manufacturing Practices) for consistent manufacturing processes.

Talented workforce: Its success is driven by a dedicated and highly skilled workforce, comprised of experts in medical device manufacturing, quality assurance, regulatory affairs, and technical support. Each team member is committed to advancing healthcare through innovation and operational excellence. From engineers and product designers to regulatory specialists and customer support professionals, its employees are at the heart of everything it does. It invests in continuous training, ensuring that its team stays at the forefront of technological advancements and better practices.

Risks and concerns

Revenue dependence on top customers: The company is dependent on certain customers for a portion of its revenues. For the period ended January 31, 2026, and for the financial years ended March 31, 2025, March 31, 2024 and March 31, 2023, its top ten customers accounted for around 46.44%, 56.82%, 69.12% and 74.79%, respectively, of its total revenue from operations. The loss of any of its major customers due to any adverse development or significant reduction in business from its major customers may adversely affect its business, financial condition, results of operations and future prospects.

Dependence on suppliers for medical devices: The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also face risks in sourcing raw materials and components from third parties for the manufacturing and assembly of its medical equipment. Any failure by its suppliers to meet agreed timelines, whether due to regulatory issues, financial difficulties, or other factors, may lead to delays, increased costs, payment issues, or damage to its reputation, all of which could adversely impact its business, operations, and financial condition.

A large portion of revenue is derived from trading sector: Its business derives a significant portion of its revenue from the trading sector, and any potential instability in this area could pose a risk to its overall performance. For the period ended January 31, 2026, and for the financial years ended March 31, 2025, March 31, 2024 and March 31, 2023, trading activities contributed around 68.44%, 72.31%, 79.60% and 83.81%, respectively, of total revenue, while manufacturing activities contributed around 30.70%, 27.32%, 20.40% and 16.19%, respectively. Any adverse effects experienced within this activity could also have a detrimental impact on its business.

Outlook

Avience Biomedicals is primarily engaged in the business of manufacturing and selling of medical consumables. Its diversified product portfolio can primarily be divided into two main categories -- Manufacturing of Medical Consumables and Distribution of branded equipment. The company aims at creating solutions that are on cutting edge with the latest advancements in the globe, having wide application and that provide cost-effective solutions for the rural and the needy. On the concern side, its revenue is significantly concentrated in its top five states, contributing a major portion of its total revenue. Any adverse economic, regulatory, or operational developments in these key regions could materially impact its business performance, revenue generation, and overall financial results. Further, it relies on limited suppliers for its products, loss of these suppliers may have an adverse effect on its business, results of operations and financial conditions.

The company is coming out with a maiden IPO of 14,53,800 equity shares of face value of Rs 10 each. The issue has been offered in a price band of Rs 196-208 per equity share. The aggregate size of the offer is around Rs 28.49 crore to Rs 30.24 crore based on lower and upper price band respectively. On performance front, its total revenue increased by 88.60% to Rs 4,596.74 lakh for the financial year 2024-25 from Rs 2,437.27 lakh for the financial year 2023-24. Net profit after tax has increased by 237.75% from Rs 214.11 lakh in Fiscal 2024 to profit of Rs 723.18 lakh in the Fiscal 2025.

Meanwhile, it develops a manufacturing facility that meets WHO and US FDA standards for medical device production. Incorporate modern technology, automation, and quality control measures to optimize efficiency and ensure compliance. Optimize its supply chain to ensure timely delivery of raw materials and components to the new plant. Consider establishing strategic partnerships with suppliers and logistics providers to enhance efficiency and reliability. Continuously monitor and evaluate the performance of the new plant, identifying opportunities for optimization and innovation. Foster a culture of continuous improvement and adaptability to maintain a competitive edge in the dynamic medical device industry.

Kratikal Tech

• Kratikal Tech is coming out with an initial public offering (IPO) of 29,40,000 shares in a price band of Rs 128-135 per equity share.
• The issue will open on June 30, 2026 and will close on July 02, 2026.
• The shares will be listed on SME Platform of BSE.
• The face value of the share is Rs 10 and is priced 12.80 times of its face value on the lower side and 13.50 times on the higher side.
• Book running lead manager to the issue is Beeline Capital Advisors.
• Compliance officer for the issue is Anmol Gupta.

Profile of the company

Kratikal Tech is engaged in providing AI-driven, Software-as-a-Service–based cybersecurity solutions through its proprietary security software platform, supported by cybersecurity and regulatory compliance services, enabling enterprises to achieve measurable cyber risk reduction and enhanced resilience. Its People Security Management (PSM) capabilities are delivered through the proprietary Threatcop platform, which focuses on reducing human-related cyber risks, and are enhanced by technology and process security offerings delivered under the Kratikal brand. Together, these offerings provide integrated protection across the People-Process-Technology stack, supporting organizations in proactively identifying, prioritizing, and mitigating cyber risks while strengthening their overall security posture in an increasingly threat environment.

Through its services, it empowers organizations to protect their critical data, prevent cyber threats, and ensure smooth business operations. Its solutions are designed to eliminate data privacy risks, safeguarding businesses from unauthorized access and security breaches. It operates through two integrated business lines: i) AI Driven People Security Management, offered through Threatcop product suite offered under Threatcop brand (Products); and ii) Technology and Process Security Services, offered under the Kratikal brand, encompassing Vulnerability Assessment and Penetration Testing (VAPT), application and infrastructure security, red-team exercises, and governance, risk and compliance (GRC) services, all supported by its AI-driven VMDR (Vulnerability Management, Detection & Response) platform and AutoSecT (Services). This integrated model enables it to address both human-layer risks and technology- and process-layer vulnerabilities within customer environments. 

In its services portfolio, it has developed Threatcop, a people security management suite and AutoSecT, an AI-driven pentest and VMDR platform. AutoSecT autonomously scans network, cloud, web, mobile, and API assets, prioritizes vulnerabilities based on risk, and provides AI-driven patch recommendations, supported by analytics dashboards for security teams and a dedicated CISO dashboard. The platform standardizes and enables the delivery of all penetration testing reports undertaken by it, enhancing scalability, consistency, and turnaround time, while embedding its intellectual property at the core of its service offerings. It has undertaken AI driven VMDR, secure code reviews, and vulnerability assessments across diverse customer environments. Its solutions are used by a broad base of small businesses and large enterprises across sectors such as banking, financial services and insurance (BFSI), fintech, telecom, IT/ITES, healthcare, pharmaceuticals, e-commerce, and manufacturing, both in India and international markets. Kratikal is a CERT-In Empanelled Security Auditor and is widely recognized for its VAPT, compliance, and virtual CISO (vCISO) services. Additionally, it is empanelled by NSE to perform system audits for trading members.

Proceed is being used for:

• Investment in Threatcop FZ LLC, UAE and Threatcop AI Inc, USA (its subsidiaries) for expenditure towards sales & marketing activities and development of workforce resources.
• Investment in product development 
• General corporate purposes 

Industry overview

The IT-BPM (Information Technology and Business Process Management) industry encompasses a broad spectrum of services, including software development, IT consulting, infrastructure management, and outsourced business processes such as finance, human resources, and customer support. This sector plays a pivotal role in India’s economic landscape, serving as a major driver of employment, innovation, and global trade. Positioned as a global leader in outsourcing and digital services, India has built a strong reputation for delivering high-quality, cost-effective IT and BPM solutions to clients across the world. The industry not only contributes significantly to foreign exchange earnings but also underpins India’s digital transformation journey, reinforcing its stature as a strategic hub for technology and business services on the global stage. 

The Indian IT-BPM sector has considerable impact on GDP and the employment rate of the country, where exports are a major contributor to the revenue from this sector. Strong supportive government policies are augmenting the consistent growth in this sector. The Software Technology Park (STP) scheme which is a 100% export-oriented scheme for development and export of computer software, including export of professional services using communication links or physical media, makes India attractive for multinational global participants to set up its presence providing employment opportunity. In addition to STP scheme, the government prioritizes cybersecurity, hyper-scale computing, Artificial Intelligence (AI) as a technology, and blockchain technology. The country, with lowest data costs at INR10/GB (USD 0.12/GB) is complimenting for a wide customer base to use this technology, which is a big advantage to train the AI for any application.

Looking further ahead, the industry is projected to generate $308.0 billion in FY 2027, $320.0 billion in FY 2028, $335.0 billion in FY 2029, and ultimately reach $350.0 billion by FY 2030. The progressive increments highlight the resilience and global competitiveness of India's IT-BPM sector. Contributing factors include the rise of Software as a Service (SaaS), global capability centres (GCCs), and government policies supporting digital public infrastructure and innovation. This consistent upward trajectory underlines the IT-BPM industry's critical role in India’s economic growth and its strategic importance in the global digital economy.

Complete people security management platform: It offers an integrated People Security Management suite through its Threatcop product stack, designed to strengthen organisational cyber resilience by addressing human-layer risks alongside technical controls. The platform includes: i) Threatcop Security Awareness Training (TSAT), a simulation-led platform for phishing and social engineering exercises along with targeted awareness content; ii) a cyber awareness Threatcop Learning Management System (TLMS); iii) Threatcop DMARC / email authentication and anti-spoofing (TDMARC); and iv) additional people-centric security capabilities such as Threatcop Phishing Incident Response (TPIR), incident readiness, and reporting modules-enabling organisations to assess, train, protect, and continuously improve user security behaviour across functions and locations.

Real-time DMARC with sender ID visibility: Its Real-Time DMARC platform provides real-time DMARC (Domain-based Message Authentication, Reporting and Conformance) enforcement with continuous monitoring of SPF/DKIM authentication outcomes and automated policy application to reduce domain spoofing and Business Email Compromise (BEC) risk. A key differentiator is Sender ID visibility, which highlights the actual sending identity behind each message (e.g., visible ‘From’ domain vs. underlying authenticated/return-path identity and sending infrastructure), helping organisations quickly detect look-alike senders, unauthorised third-party senders, and misaligned authentication. This improves security teams’ ability to triage incidents faster, validate legitimate marketing/transactional senders, and maintain stronger control over email channels across business units and vendors.

Comprehensive coverage across security domains: It offers a wide range of cybersecurity solutions covering multiple layers of an organisation’s digital infrastructure. Its service portfolio includes vulnerability assessment and penetration testing across networks, cloud environments, web and mobile applications and APIs, as well as cloud security posture reviews, configuration assessments and application-level security testing. In addition, it provides compliance audits, governance advisory and regulatory support aligned with applicable industry standards and statutory requirements. This comprehensive coverage enables it to serve customers with varied security maturity levels, operating environments and regulatory obligations. By addressing both technical vulnerabilities and governance-related gaps, it is able to deliver integrated security solutions rather than isolated point services. This breadth of capabilities also supports cross-selling and upselling of complementary services within existing customer relationships, enhances account depth, and reduces reliance on single-service engagements.

Risks and concerns

Dependence on human capital: It has 200 employees on payroll. Being a cyber-security company, a huge percentage of its revenue is diverted towards the employee benefit expenses. Its employees are key to its success in business operations. If it experiences a slowdown or stoppage of work for any client for which it has dedicated employees, it may not be able to efficiently reallocate these employees to other clients and projects to keep their utilization and productivity levels high. Its ability to execute projects and to obtain new clients depends largely on their ability to attract, train, motivate and retain highly skilled professionals. The performance of it will be benefited on the continued service of these persons or replacement of equally competent persons from the domestic markets. It may have difficulty in redeploying and retraining its professionals to keep pace with continuing changes in technology, evolving standards and changing customer.

Revenue dependence on key customers: Its top ten customers contribute 31.60%, 21.89% and 25.11% of its total revenue from operations for the financial year ended on March 31, 2026, 2025 and 2024, respectively. It is engaged in the business of risk-based vulnerability management and assessment solutions, cybersecurity quantification, cyber security, and services of penetration testing services. Its business operations are highly dependent on its customers and the loss of any of its customers may adversely affect its sales and consequently on its business and results of operations.

Geographical concentration risk: The company’s revenues are geographically concentrated, with the top six states Delhi, Haryana, Karnataka, Maharashtra, Tamil Nadu and Uttar Pradesh contributing majority of the total revenues during each of the periods. Its top six states contribute 63.07%, 78.71% and 78.89% of its total revenue for the financial year ended on March 31, 2026, 2025 and 2024, respectively. As a result, its business performance is dependent, to a considerable extent, on market conditions, customer demand, regulatory environment and economic activity in these regions. Accordingly, any adverse changes in market conditions, regulatory environment or economic activity in these States could have a material impact on the company’s business, results of operations and financial condition. 

Outlook

Kratikal Tech is engaged in providing AI-driven, Software-as-a-Service–based cybersecurity solutions through its proprietary security software platform, supported by cybersecurity and regulatory compliance services, enabling enterprises to achieve measurable cyber risk reduction and enhanced resilience. Its empanelment with the Indian Computer Emergency Response Team (CERT-In) represents a significant strength and provides a distinct competitive advantage, particularly in engagements with government bodies, public sector undertakings and large enterprises. This empanelment reflects its technical capabilities, process maturity and adherence to prescribed cybersecurity standards and guidelines. On the concern side, it does not successfully anticipate market needs or develop and introduce new solutions that meet users’ needs on a timely basis, it may not be able to compete effectively and its revenue, reputation, financial conditions, results of operations and cash flows may be adversely affected. Moreover, a significant portion of its revenues is generated during the last quarter of the financial year, and any delay or reduction in customer spending during this period may materially affect its annual financial performance.

The company is coming out with a maiden IPO of 29,40,000 equity shares of face value of Rs 10 each. The issue has been offered in a price band of Rs 128-135 per equity share. The aggregate size of the offer is around Rs 37.63 crore to Rs 39.69 crore based on lower and upper price band respectively. On performance front, the revenue from operations of the company for FY25-26 was Rs 3,671.59 lakh as against Rs 2,085.09 lakh for FY24-25, an increase of 76.09%. Profit after tax for the FY25-26 was at Rs 614.25 lakh as against profit after tax of Rs 381.44 lakh in FY24-25, an increase of 61.03%.

It intends to pursue international expansion through a combination of organic initiatives and strategic arrangements, including tie-ups, acquisitions, strategic alliances, partnerships or joint ventures, where considered appropriate. In addition, it plans to strengthen its global market presence by investing in brand building, targeted advertising, marketing activities and development of workforce resources in key overseas geographies. These initiatives are aimed at expanding customer acquisition, deepening relationships with international clients and diversifying revenue streams, while leveraging its existing technical capabilities and delivery model. Going forward, it plans to strengthen its product development capabilities through ongoing investments in research and development, technology infrastructure and skilled human resources. This includes hiring and retaining experienced professionals across product engineering, cybersecurity research, artificial intelligence, cloud security and DevSecOps functions. In addition to organic investments, it may pursue selective acquisitions, strategic investments or licensing arrangements for technologies that complement and enhance its existing product portfolio.

Vinit Mobile 

• Vinit Mobile is coming out with an initial public offering (IPO) of 21,60,000 shares in a price band of Rs 150-158 per equity share. 
• The issue will open on June 30, 2026 and will close on July 2, 2026.
• The shares will be listed on SME Platform of NSE.
• The face value of the share is Rs 10 and is priced 15.00 times of its face value on the lower side and 15.80 times on the higher side.
• Book running lead manager to the issue is Comfort Securities.
• Compliance officer for the issue is Mansi Jain.

Profile of the company

Vinit Mobile deals in a wide range of mobile handsets of most of the major brands in India which includes Apple, One Plus, Motorola, Samsung, Vivo, Oppo, Realme and Xiaomi etc. Alongside smartphones, its stores also stock mobile related products such as tablets, data cards, and a variety of accessories like earphones, chargers, power banks, screen guards and mobile covers, all available under one roof across its retail outlets. The company follows a Company-Owned and Company-Operated (“COCO”) model, whereby its retail stores are owned and operated by the Company. Under this model, the company directly manages store operations, including recruitment and training of personnel, inventory planning and replenishment, pricing and promotional execution, and customer service procedures. The COCO model supports consistency in operating practices across its retail network.

The company has arrangements with various financial institutions, including Bajaj Finserv, HDB Financial Services, and TVS Credit, to facilitate point-of-sale financing and EMI options for customers at its stores, subject to eligibility and approval by such institutions. In addition, the company facilitates after-sales support for mobile phones and accessories through authorized service centers for warranty-related repairs or services. 

The company provides after-sales assistance to customers for mobile phones and accessories sold through its stores. Such assistance includes facilitating access to authorized service centers for maintenance, repair, or warranty-related services. All mobile phones and accessories are sold with standard manufacturer warranties. The Company coordinates with suppliers and service centers to address customer complaints relating to defective products, in accordance with applicable warranty terms. Moreover, the company provides free home delivery for selected purchases. the company also undertakes promotional schemes during festive periods, including discount and cashback-based offers, in accordance with applicable terms and conditions.

Proceed is being used for:

• The proceeds will be utilized to establish new retail stores across strategic locations to enhance market presence and drive revenue growth
• Working capital funds will support day-to-day operational requirements, including inventory, vendor payments, and other short-term financial obligations
• General corporate purposes to meet general business needs such as brand development, technology upgrades, and other strategic initiatives to support overall growth

Industry overview 

India’s rise to the world’s 2nd-largest mobile phone manufacturer. India’s mobile phone production has shown strong and sustained growth over the past few years, increasing from $30.00 billion in 2020-21 to $59.12 billion in 2024-25. This growth is expected to accelerate sharply, with production projected to reach USD 124.06 billion by 2029-30, more than doubling in five years growing at a CAGR of 15.98%. The expansion is driven by rising domestic demand, increasing exports, supportive government policies such as open network for Digital Commerce (ONDC) and India’s emergence as a major global manufacturing hub. The trend also reflects improvements in technology adoption, and investments in production infrastructure, positioning India as a key player in the global mobile phone industry.

The Mobiles phones & accessories retail distribution market ecosystem in India is undergoing a structural transformation, supported by rising smartphone adoption, improving retail penetration beyond metropolitan markets, and increasing digitalization across supply chains. Mobile accessories benefit from recurring demand, shorter replacement cycles, and strong linkage with smartphone sales, making the segment resilient and scalable. Over the medium to long term, policy support for expansion of organized retail formats, and improved access to financing are expected to enhance distribution efficiency, inventory turnover, and margin sustainability for retailers and distributors operating in this segment.

The mobile phone and accessories retail distribution market in India is entering a strong structural growth phase, supported by favorable macroeconomic trends, rising digital adoption, and sustained policy support. Increasing disposable incomes, rapid urbanization, and deeper smartphone penetration across Tier II & III cities are expanding the consumer base, while shorter handset replacement cycles are driving repeat purchases. Alongside handset growth, demand for mobile accessories - including chargers, earphones, power banks, wearables, and smart peripherals-is expected to grow at a faster pace due to higher attach rates, evolving technology standards, and rising consumer awareness around safety, performance, and brand reliability.

Pros and strengths

Company Owned Company Operated Stores: The company operates under a Company-Owned and Company-Operated (COCO) retail model, under which it owns and manages its retail outlets. This model enables the Company to directly manage store level operations, including staffing, inventory management, billing processes, and supervision across its retail network.

Strategic store locations and customer experience: The company operates retail stores across multiple locations within Surat district of Gujarat. Each store is configured to display mobile phones and accessories available for sale, allowing customers to view and examine products prior to purchase. Sales personnel at the stores assist customers by providing product-related information and facilitating the purchase process.

Innovative gift baskets to attract customers: The company offers promotional schemes at its retail outlets, which may include gift baskets provided to customers at the time of purchase during specific promotional or festive periods. Such gift baskets may include mobile accessories and other promotional items, as determined by the company from time to time.

Risks and concerns

Business is highly dependent on the brand recognition and reputation: The company is engaged in the multi-brand retail business, specializing in the sale of smartphones and allied accessories from leading global brands such as Apple, Samsung, Realme, Xiaomi, Oppo, Vivo, Motorola, Techno, Infinix, and others. Though it ais not required to promote the products of these well-known brands, it competes on price, quality services, dedication and commitment towards customers, in its industry.  Its financial performance is closely tied to the market success of the brands it sells. This success depends on various factors, including product design and features, brand identity, product quality, after-sales service, marketing strategies, public relations, and overall consumer perception. Customers who choose branded products generally expect a consistently high standard of quality and service. Any failure by these brand owners to meet those expectations whether due to product issues, poor customer experience, or negative publicity can adversely impact consumer trust. This, in turn, could negatively affect its sales, reputation, and overall business performance. 

Dependence on limited number of suppliers: The company is significantly dependent on a limited number of suppliers for the procurement of products. The company's top 10 suppliers accounted for 83.21%, 92.32%, 93.24% and 100.00% of its total purchases for the period ended December 31, 2025 and Fiscal 2025, Fiscal 2024 and Fiscal 2023, respectively. Any disruption, delay, or termination of business relationships with one or more of these key suppliers could adversely affect its ability to maintain inventory levels, fulfill customer demand, and operate efficiently.

Dependence on Gujarat market exposes company to geographic concentration risk: The company’s operations and revenues are limited to and concentrated in the geographical region of the State of Gujarat. Revenue from operations upto December 31, 2025, are generated within Surat district of Gujarat, India only. This geographical limitation could pose challenges to its long-term growth, as the continuous addition of new stores within a confined region increases the risk of market saturation. A saturated market may lead to reduced returns, as the customer base could be spread thinly across multiple outlets, thereby impacting overall profitability. Expanding in other districts and beyond Gujarat is essential for sustainable growth but would require considerable investment, strategic planning, and operational adjustments. Inability to manage market saturation effectively or to successfully expand into new regions may hinder its scalability and negatively impact on its financial performance.

Outlook

Vinit Mobile is engaged in the multi-brand retail business, specializing in the sale of smartphones and allied accessories from leading global brands such as Apple, Samsung, Realme, Xiaomi, Oppo, Vivo, Motorola, Techno, Infinix, and others. The company follows a COCO model, whereby its retail stores are owned and operated by the company. On the concern side, its business is primarily focused on the distribution of telecom products, such as mobile devices, accessories, and related gadgets, which leaves it vulnerable to risks due to the lack of diversification in its product offerings. Further, the mobile phone and accessories market is highly dynamic, with frequent price fluctuations driven by rapid technological advancements, product launches, changes in demand, and intense competition. Sudden drops in prices, particularly for older models, can lead to inventory devaluation, adversely affecting its margins and profitability.

The company is coming out with a maiden IPO of 21,60,000 equity shares of face value of Rs 10 each. The issue has been offered in a price band of Rs 150-158 per equity share. The aggregate size of the offer is around Rs 32.40 crore to Rs 34.13 crore based on lower and upper price band respectively. On performance front, the company’s revenue from operations increased by 110.02% from Rs 2,856.32 lakh in FY 2023-24 to Rs 5,998.86 lakh in FY 2024-25. Profit for the period increased from Rs 71.99 lakh in FY 2023-24 to Rs 390.21 lakh in FY 2024-25.

Meanwhile, the company is working towards developing a multi-channel sales platform, combining in-store experience with WhatsApp commerce and online ordering. The company has initiated preliminary steps regarding this, which includes development of its own ecommerce website and has undertaken marketing initiatives via print media like advertisement in local newspapers, distribution of pamphlets and social media platforms like WhatsApp, Instagram and Facebook to engage with existing and potential customers, creating awareness about digital ordering options. The company facilitates direct customer engagement through an ‘Enquire Now’ feature embedded on each product page of its e-commerce website. This feature redirects prospective customers to the company's WhatsApp business platform, enabling real-time communication with authorized Company representatives to address specific product inquiries and requirements.

In continuation of its earlier intimations dated 13th February, 2026 and 06th March, 2026, wherein the Stock Exchanges were informed that Alkem Medtech, a wholly owned subsidiary of the Company in India (‘Alkem Medtech’), intends to acquire at least 51% and up to 55% of the total issued equity share capital of Occlutech Holding AG(‘Occlutech’), a company incorporated in Switzerland and had executed Share Purchase Agreement with the selling shareholders of Occlutech respectively. In this regard, Alkem Laboratories has informed that on 26th June, 2026, Alkem Medtech has executed First Supplementary Agreement to Share Purchase Agreement dated 6th March, 2026 with the selling shareholders of Occlutech. A copy of this disclosure will be made available on the Company’s website in accordance with Regulation 30(8) of the SEBI LODR Regulations.

The above information is a part of company’s filings submitted to BSE.